News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,395 Results
Type
Article (40368)
Company Profile (303)
Press Release (647724)
Section
Business (204981)
Career Advice (2044)
Deals (35539)
Drug Delivery (87)
Drug Development (81119)
Employer Resources (169)
FDA (16181)
Job Trends (14889)
News (346374)
Policy (32659)
Tag
Academia (2567)
Alliances (49445)
Alzheimer's disease (1223)
Approvals (16097)
Artificial intelligence (114)
Bankruptcy (354)
Best Places to Work (11502)
Biotechnology (213)
Breast cancer (106)
Cancer (898)
Cardiovascular disease (80)
Career advice (1712)
Cell therapy (197)
Clinical research (64153)
Collaboration (326)
Compensation (167)
COVID-19 (2546)
Cystic fibrosis (78)
Data (849)
Diabetes (133)
Diagnostics (6116)
Earnings (84322)
Employer resources (147)
Events (109481)
Executive appointments (241)
FDA (16623)
Funding (290)
Gene therapy (147)
GLP-1 (565)
Government (4348)
Healthcare (18727)
Infectious disease (2619)
Inflammatory bowel disease (106)
Interviews (327)
IPO (16328)
Job creations (3680)
Job search strategy (1454)
Layoffs (414)
Legal (7921)
Lung cancer (154)
Manufacturing (150)
Medical device (13231)
Medtech (13236)
Mergers & acquisitions (19223)
Metabolic disorders (362)
Neuroscience (1463)
NextGen Class of 2024 (6554)
Non-profit (4480)
Northern California (1200)
Obesity (213)
Opinion (183)
Patents (95)
People (56500)
Phase I (19892)
Phase II (28241)
Phase III (21084)
Pipeline (206)
Postmarket research (2586)
Preclinical (8470)
Radiopharmaceuticals (234)
Rare diseases (179)
Real estate (5939)
Regulatory (21565)
Research institute (2324)
Resumes & cover letters (350)
Southern California (1080)
Startups (3623)
United States (11619)
Vaccines (538)
Weight loss (161)
Date
Today (163)
Last 7 days (802)
Last 30 days (2785)
Last 365 days (35869)
2024 (30412)
2023 (40236)
2022 (51363)
2021 (55925)
2020 (54275)
2019 (46756)
2018 (35238)
2017 (32316)
2016 (31757)
2015 (37816)
2014 (31602)
2013 (26642)
2012 (28932)
2011 (29569)
2010 (27718)
Location
Africa (723)
Arizona (187)
Asia (37414)
Australia (6147)
California (2729)
Canada (1170)
China (210)
Colorado (118)
Connecticut (120)
Europe (80294)
Florida (392)
Georgia (98)
Illinois (309)
Indiana (177)
Kansas (96)
Maryland (513)
Massachusetts (2204)
Michigan (142)
Minnesota (249)
New Jersey (819)
New York (829)
North Carolina (669)
Northern California (1200)
Ohio (127)
Pennsylvania (744)
South America (1103)
Southern California (1080)
Texas (383)
Utah (79)
Washington State (322)
688,395 Results for "pressure biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET
Pressure BioSciences, Inc. announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics.
June 13, 2024
·
4 min read
Genetown
Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics.
June 18, 2024
·
4 min read
Business
Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update
Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to discuss its Third Quarter 2023 financial results and to provide a business update.
November 20, 2023
·
5 min read
Genetown
Pressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction
Pressure BioSciences, Inc. today announced the closing of its acquisition of natural health and wellness leader Uncle Bud’s (“UB”) in an all-stock transaction.
January 22, 2024
·
7 min read
Business
Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023
Pressure BioSciences, Inc. today reported financial results for the third quarter ended September 30, 2023, provided a business update, and offered limited guidance for expected achievements through the remainder of 2023.
November 21, 2023
·
11 min read
Genetown
Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies
Pressure BioSciences, Inc. announced they are actively pursuing and evaluating multiple artificial intelligence and machine learning prospective partnerships.
January 4, 2024
·
6 min read
Genetown
Pressure BioSciences’ Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform
Pressure BioSciences, Inc. today announced the publication of a powerful visionary article in the respected industry trade magazine “Food Technology” published by the Institute of Food Technologists (“IFT”).
December 21, 2023
·
7 min read
Business
Uncle Bud’s to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness
Pressure BioSciences, Inc. is hosting a teleconference today (Monday, February 5th, 4:30PM EST) to discuss the recent acquisition of natural health and wellness innovator Uncle Bud’s (“UB”), as well as other on-going opportunities.
February 5, 2024
·
7 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
1 of 68,840
Next
